Intuitive Surgical (NASDAQ: ISRG) has demonstrated strong performance over the past five years, successfully navigating challenges posed by the pandemic and economic conditions, with its shares surpassing broader market gains. However, the competitive landscape is evolving, raising questions about the company’s future performance. Stakeholders are keen to understand how Intuitive Surgical will adapt and thrive through 2031. As changes unfold, the focus remains on the company’s ability to maintain its leadership in the medical device industry.
Loading PerspectiveSplit analysis...






